🔍 Is Your R&D Strategy Future-proof? Pharma R&D spending is more than just a financial commitment - it's a strategic investment in the future. However, not all R&D bets are equal. As alluded to in an earlier post, for some companies likelihood of first approval is more of a reflection of their R&D strategy rather than their R&D productivity. For others, it may be a pure function of luck. Moderna's bold R&D spending reflects its drive for innovation while Merck's strategic acquisitions and collaborations highlight a cautious approach to maintaining competitive advantage. Swipe through to check out how pharma players rank based on their R&D spending and how they balance innovation with financial sustainability. Which of these companies do you find have the optimal approach to R&D and are best placed to see sustainable innovation in the coming future? Comment below 👇to share your thoughts #AtacanaGroup #Pharma #RandD #Innovation #Biotech #Strategy #CompetitiveAdvantage #HealthcareInnovation #Moderna #Merck
Empowering and optimizing business with AI driven competitive intelligence; Consultant at Atacana (Certified Scrum Master)
4dGood Insights! R&D strategy is a delicate balance between bold innovation vs. sustainable growth. Moderna bets big on breakthroughs, while Merck diversifies with strategic deals